BioTeSys GmbH   Report issue

For profit Phase 1
Founded: Esslingen Germany (1999)

Organization Overview

First Clinical Trial
2011
NCT02548247
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

BioTeSys GmbH | CRO BioTeSys GmbH